IP Library › Granted Patent US 12,435,056
Granted Patent B2
US 12,435,056 · App. 17/484,929 · Granted Oct 7, 2025

N-lipoic-amino acid or peptide, derivatives and their uses

Inventors: Ruey J. Yu (Chalfont, PA); Eugene J. Vanscott (Abington, PA)
Assignee: Neostrata Company, Inc.
C07D339/04A61K8/44A61K8/4986A61K8/64A61Q19/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,435,056
App. No.
17/484,929
Granted
Oct 7, 2025
Kind
B2
Abstract

Novel compounds of N-Lipoic-amino acid, N-Lipoic-peptides and their derivatives are described. Also described are compositions and method of compostions containing the derivatives of the amino acids or peptides, and their uses including treating and preventing dermatological or cosmetic conditions or other disorders of the cutaneous system. Compositions and methods of using the compositions for skin lightening and cosmetics are also disclosed.

Claims (16)

1. A method of treating a cosmetic condition or dermatological disorder selected from the group consisting of fine lines, wrinkles, age spots, skin lightening, disturbed keratinization, and changes associated with intrinsic and extrinsic aging comprising topically administering to a subject a composition comprising therapeutically effective amount of a compound having the following structure (I):

2. The method of claim 1 , wherein the composition further comprises an ingredient selected from the group consisting of water, ethanol, propylene glycol, oleyl lactate, and combinations thereof.

3. The method of claim 1 , wherein the composition further comprises an ingredient selected from the group consisting of a sunscreen, an anti-acne compound, an anti-microbial compound, an anti-inflammatory compound, an antioxidant, a chelating compound, a pH adjuster, an emollient, a thickening compound, a preservative, an emulsifier, a humectant, a moisturizer, a suspending compound, an optical brightener, a stabilizer, a penetration enhancer, a perfume, a coloring compound, and combinations thereof.

4. The method of claim 1 , wherein, the composition is in the form of a liquid, lotion, cream, serum, gel, soap bar or toner, or applied via a face mask or patch.

5. The method of claim 1 , wherein the composition is topically administered to the skin on the face, neck, chest, back, arms, hands, legs and/or scalp.

6. The method of claim 5 , wherein the composition is topically administered to the skin on the face.

7. The method of claim 1 , wherein the composition comprises about 0.01 to about 20% by weight, of the compound.

8. The method of claim 1 , wherein the composition comprises about 0.001 to about 2% by weight, of the compound.

9. A method of lightening skin, the method comprising topically administering to the skin of a subject a composition comprising therapeutically effective amount of a compound having the following structure:

10. The method of claim 9 , wherein the composition further comprises an ingredient selected from the group consisting of water, ethanol, propylene glycol, oleyl lactate, and combinations thereof.

11. The method of claim 9 , wherein the composition further comprises an ingredient selected from the group consisting of a sunscreen, an anti-acne compound, an anti-microbial compound, an anti-inflammatory compound, an antioxidant, a chelating compound, a pH adjuster, an emollient, a thickening compound, a preservative, an emulsifier, a humectant, a moisturizer, a suspending compound, an optical brightener, a stabilizer, a penetration enhancer, a perfume, a coloring compound, and combinations thereof.

12. The method of claim 9 , wherein, the composition is in the form of a liquid, lotion, cream, serum, gel, soap bar or toner, or applied via a face mask or patch.

13. The method of claim 9 , wherein the composition is topically administered to the skin on the face, neck, chest, back, arms, hands, legs and/or scalp.

14. The method of claim 13 , wherein the composition is topically administered to the skin on the face.

15. The method of claim 9 , wherein the composition comprises about 0.01 to about 20% by weight, of the compound.

16. The method of claim 9 , wherein the composition comprises about 0.001 to about 2% by weight, of the compound.

Continuity (2)
Continuation 16083924
Related Publication 20220127242A1 · Apr 28, 2022
References Cited (29)
US 3238224A · Ohara · 1966 [cited by examiner]
US 11155531B2 · Yu · 2021 [cited by examiner]
US 20070231284A1 · Pinel · 2007 [cited by applicant]
US 20080200396A1 · Hocquaux · 2008 [cited by applicant]
US 20110082192A1 · Milne · 2011 [cited by applicant]
US 20110257130A1 · Rajogopal · 2011 [cited by applicant]
US 20150329519A1 · Kates et al. · 2015 [cited by applicant]
CN 1208035A · 1999 [cited by applicant]
EP 1070710 · 2001 [cited by applicant]
JP H11269170A · 1999 [cited by applicant]
JP 2003048833A · 2003 [cited by applicant]
JP 2003286168A · 2003 [cited by examiner]
JP 2006022066A1 · 2006 [cited by applicant]
JP 2016000157A · 2014 [cited by applicant]
WO WO0193824A · 2001 [cited by applicant]
WO WO2005115174A2 · 2005 [cited by applicant]
WO WO2009003284A1 · 2009 [cited by applicant]
WO WO2009020317A2 · 2009 [cited by applicant]
“Topical preparation useful as cosmetics for skin whitening and for 30 preventing or treating freckles, wrinkles and suntan, contains N-(alpha)-lipoyl amino acid or its salt”, PN-JP2003286168 A20031007 DW200382, the abs… [cited by applicant]
Database WPI Week 200382. Thomson Scientific, London, GB; AN 2003-885517 XP002794570 & JP 2003286168 A (Senju Seiyaku KK) Oct. 7, 2003 *abstract*. [cited by applicant]
Lu Chichong et al: “Synthesis of lipoic acid-peptide conjugates and their effect on collagen and melanogene”, European Journal of Medicinal Chemistry, Elsevier, Amsterdam, NL, vol. 69, Sep. 18, 2013 (Sep. 18, 2013), pp.… [cited by applicant]
Yoshio Viii Deguchi et al: “Studies on the Synthesis of Thioctic Acid and its Related Compounds”, Pharmaceutical Journal, vol. 83, No. 7, Jul. 25, 1963 (Jul. 25, 1963), pp. 733-737, XP55625496, DOI: 10.1248/yakushi1947.… [cited by applicant]
Maria Laura Bolognesi et al: “Synthesis of New Lipoic Acid Conjugates and Evaluation of Their Free Radical Scavenging and Neuroprotective Activities”, Chemical Biology & Drug Design, vol. 83, No. 6, Jun. 1, 2014 (Jun. 1… [cited by applicant]
Koji Daigo et al: “Synthesis of some N-lipoyl amino acids and peptides”, Journal of the American Chemical Society, vol. 84, No. 4, Feb. 1, 1962 (Feb. 1, 1962), pp. 662-665, XP55625481. Example compounds. [cited by applicant]
Di Stefano A et al: “L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties”, Journal of Medicinal Chemistry, American Chemical Society, US, vol. 49, No. 4, Feb. 23,… [cited by applicant]
Steven A. Kates et al: “Lipoic acid analogs with enhanced pharmacological activity”, Bioorganic & Medicinal Chemistry, vol. 22, No. 1, Jan. 1, 2014 (2014-01-01), pp. 505-512, XP055118599, ISSN: 0968-0896, DOI: 10.1016/j… [cited by applicant]
Database WPI Week 200350. Thomson Scientific, London, GB; AN 2003-527674. XP002794571 & JP 2003 048833 A (Senju Seiyaku KK) Feb. 21, 2003 (Feb. 21, 2003) *abstract*. [cited by applicant]
Supplementary European Search Report for EP16894728 dated Sep. 25, 2019. [cited by applicant]
Extended Search Report for EP21217352.0 dated May 27, 2022. [cited by applicant]